IBM Security Verify Access Reverse Proxy denial of service
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $0-$5k | 1.07- |
Summary
A vulnerability, which was classified as problematic, has been found in IBM Security Verify Access, Security Verify Access Container, Verify Identity Access and Verify Identity Access Container. Impacted is an unknown function of the component Reverse Proxy. Performing a manipulation results in denial of service. This vulnerability is cataloged as CVE-2026-11937. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability was found in IBM Security Verify Access, Security Verify Access Container, Verify Identity Access and Verify Identity Access Container (affected version unknown). It has been classified as problematic. This affects an unknown functionality of the component Reverse Proxy. The manipulation with an unknown input leads to a denial of service vulnerability. CWE is classifying the issue as CWE-404. The product does not release or incorrectly releases a resource before it is made available for re-use. This is going to have an impact on availability. The summary by CVE is:
IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3 and IBM Verify Identity Access Container 11.0 through 11.0.3 and IBM Security Verify Access Container 10.0 through 10.0.9.2 Reverse Proxy in certain configurations is vulnerable to a denial of service attack.
The advisory is shared at ibm.com. This vulnerability is uniquely identified as CVE-2026-11937 since 06/10/2026. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 08/12/2026). MITRE ATT&CK project uses the attack technique T1499 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
- Security Verify Access
- Security Verify Access Container
- Verify Identity Access
- Verify Identity Access Container
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Denial of serviceCWE: CWE-404
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
06/10/2026 CVE reserved08/12/2026 Advisory disclosed
08/12/2026 VulDB entry created
08/12/2026 VulDB entry last update
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2026-11937 (🔒)
GCVE (CVE): GCVE-0-2026-11937
GCVE (VulDB): GCVE-100-389229
Entry
Created: 08/12/2026 22:20Changes: 08/12/2026 22:20 (53)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.